 |
|
Submission of Data Sets to Journals: What's the Real Issue?
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
As a clinical pharmacologist (G.D.N.) and biostatistician (R.S.C.) involved in the design, analysis, and reporting of hundreds of controlled clinical trials, we found the 2 editorials on the publication of raw data for clinical studies to be quite thought provoking.1-2 Dr Wilhelmus proposes that making data sets available might decrease the potential for misconduct and allow for greater potential pooling for meta-analyses. Drs Beck and Ferris respond to these suggestions, stating that while actual computational errors and inappropriate analyses may be an issue, more often it is the actual protocol design or study conduct that is of greater concern. Regarding the use of these large data sets for manuscript review, they point out the problems with finding the large amounts of skilled person-power required to perform such analyses.
We were concerned with the motivation for a request for raw data—the issue of potential misconduct. Is this an effort to protect . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Submission of Data Sets to Journals: Opportunities for Improving Good Research Practice
Wilhelmus
Arch Ophthalmol 2001;119:623-623.
FULL TEXT
|
